Large-scale testing (Phase 3)Study completedNCT00018941What this trial is testingInterleukin-2 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT03866382What this trial is testingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsWho this might be right forBladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more National Cancer Institute (NCI) 314
Not applicableLooking for participantsNCT06194669What this trial is testingMechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule CellsWho this might be right forCarcinoma, Renal CellVon Hippel-Lindau Disease IRCCS San Raffaele 50
Early research (Phase 1)WithdrawnNCT03189186What this trial is testingPhase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell CarcinomasWho this might be right forRenal Cell CarcinomaMetastatic Kidney Cancer University of California, Irvine
Not applicableLooking for participantsNCT06965192What this trial is testingDesigning Visual Tools to Enhance Cancer Surgeon Decision-makingWho this might be right forProstate CancerKidney Cancer UNC Lineberger Comprehensive Cancer Center 220
Large-scale testing (Phase 3)Study completedNCT00606632What this trial is testingPre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-AntibodyWho this might be right forRenal Cell CarcinomaKidney Cancer Heidelberg Pharma AG 226
Very early researchStudy completedNCT00276835What this trial is testingGenistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Northwestern University 15
Early research (Phase 1)Study completedNCT00351949What this trial is testingIMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)Who this might be right forStage IV Renal Cell Carcinoma Immutep S.A.S. 24
Large-scale testing (Phase 3)Study completedNCT00003126What this trial is testingInterleukin-2 in Treating Patients With Stage III or Stage IV Kidney CancerWho this might be right forKidney Cancer Loyola University 69
Testing effectiveness (Phase 2)Looking for participantsNCT06161532What this trial is testingSacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...Who this might be right forSmall Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more National Cancer Institute (NCI)
Not applicableStudy completedNCT03606044What this trial is testing3D Virtual Models as an Adjunct to Preoperative Surgical PlanningWho this might be right forKidney NeoplasmsSurgical Oncology Dr Eoin R Hyde 24
Testing effectiveness (Phase 2)Study completedNCT00045487What this trial is testingErlotinib in Treating Patients With Advanced Kidney CancerWho this might be right forKidney Cancer The University of Texas Health Science Center at San Antonio 41
Testing effectiveness (Phase 2)Study completedNCT04718584What this trial is testingThe Efficacy and Safety of LDP in Patients With Urinary and Male Genital TumorsWho this might be right forBladder CancerRenal CarcinomaAdvanced Penile Carcinoma Dragonboat Biopharmaceutical Company Limited 27
Not applicableWithdrawnNCT06603155What this trial is testingTime Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)Who this might be right forMetastatic Head-and-neck Squamous-cell CarcinomaUnresectable Renal Cell CarcinomaMetastatic Renal Cell Carcinoma Duke University
Early research (Phase 1)Study completedNCT00039052What this trial is testingIntravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast CancerWho this might be right forBreast CancerKidney CancerLung Cancer Neurocrine Biosciences
Testing effectiveness (Phase 2)WithdrawnNCT03927248What this trial is testingPAC-1 for Treatment of Refractory, Metastatic Kidney CancerWho this might be right forMetastatic Renal Cell Carcinoma HealthPartners Institute
Testing effectiveness (Phase 2)Ended earlyNCT02122003What this trial is testingSecond Line Sorafenib After Pazopanib in Patients With RCCWho this might be right forMetastatic Renal Cell Carcinoma Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 16
Not applicableLooking for participantsNCT07680556What this trial is testingPromoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell CarcinomaWho this might be right forOncology Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00077129What this trial is testingPaclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell CancerWho this might be right forKidney Cancer Eastern Cooperative Oncology Group 22
Testing effectiveness (Phase 2)UnknownNCT03827837What this trial is testingFamitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological TumorsWho this might be right forRenal Cell CarcinomaUrothelial CarcinomaCervical Cancer+2 more Jiangsu HengRui Medicine Co., Ltd. 265